Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹29,806.8
₹63,338 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,438.5
₹30,466 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹832.4
₹7,545 Cr
Pharmaceuticals & Drugs
₹460.7
₹7,250 Cr
Pharmaceuticals & Drugs
₹518.2
₹4,729 Cr
Pharmaceuticals & Drugs
₹313.0
₹3,503 Cr
Pharmaceuticals & Drugs
₹100.0
₹2,567 Cr
Pharmaceuticals & Drugs
₹788.4
₹450 Cr
Pharmaceuticals & Drugs
₹58.5
₹285 Cr
Pharmaceuticals & Drugs
₹87.3
₹248 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,438.5
₹4,806 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹460.7
₹4,123 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹518.2
₹2,422 Cr
Pharmaceuticals & Drugs
₹832.4
₹1,946 Cr
Pharmaceuticals & Drugs
₹313.0
₹668 Cr
Pharmaceuticals & Drugs
₹100.0
₹221 Cr
Pharmaceuticals & Drugs
₹58.5
₹85 Cr
Pharmaceuticals & Drugs
₹29,806.8
₹6,590 Cr
Pharmaceuticals & Drugs
₹788.4
₹327 Cr
Pharmaceuticals & Drugs
₹87.3
₹449 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,438.5
₹930 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹460.7
₹347 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹832.4
₹268 Cr
Pharmaceuticals & Drugs
₹518.2
₹189 Cr
Pharmaceuticals & Drugs
₹100.0
₹145 Cr
Pharmaceuticals & Drugs
₹313.0
₹139 Cr
Pharmaceuticals & Drugs
₹58.5
₹4 Cr
Pharmaceuticals & Drugs
₹29,806.8
₹1,452 Cr
Pharmaceuticals & Drugs
₹788.4
₹6 Cr
Pharmaceuticals & Drugs
₹87.3
₹4 Cr

You may also like the below Video Courses